Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

NeoGenomics Company Profile (NYSE:NEO)

Consensus Ratings for NeoGenomics (NYSE:NEO) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.20 (15.03% upside)

Analysts' Ratings History for NeoGenomics (NYSE:NEO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/14/2014Dawson JamesInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014Longbow ResearchInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014Roth CapitalInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
2/14/2014StephensInitiated CoverageOverweight$6.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2014William BlairInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/23/2013ZacksReiterated RatingOutperform -> Outperform$7.00ViewTweet This Rating  Share This Rating on StockTwits
5/1/2013SidotiInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
4/25/2013Ladenburg ThalmannDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
2/14/2013Ladenburg ThalmannBoost Price TargetBuy$3.50 -> $3.75ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2012 forward)